這位與默克和 Travere 相關的生物技術交易者正處於獲利回吐的區間

Ligand 股票在週四進入了獲利了結區，原因是其強勁的第二季度報告和上調的盈利指引

Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike.